Key result
Over 50% of older patients with severe symptomatic mitral regurgitation are denied surgery due to high perioperative mortality and questionable quality of life benefits.
Discusses the role of transcatheter mitral valve edge-to-edge repair as an alternative for older patients with severe symptomatic mitral regurgitation who are denied surgery due to high perioperative risk.
More than 10% of people 75 years and older suffer from severe symptomatic mitral regurgitation (1). This number even increases with increasing age. Whereas mitral valve repair and replacement is the gold standard in younger patients with normal left ventricular function, surgical risk dramatically increases with increasing age and impairment of left ventricular function. Fifty percent and more patients with severe symptomatic mitral valve regurgitation are denied surgery (2) due to high perioperative mortality, unsatisfactory longterm survival, and questionable benefit on quality of life (3), especially in older patients.
No takes yet. Share an insight, caveat, or question.
Tienush Rassaf (2017) conducted an editorial in Severe symptomatic mitral regurgitation. Transcatheter mitral valve edge-to-edge repair was evaluated. Over 50% of older patients with severe symptomatic mitral regurgitation are denied surgery due to high perioperative mortality and questionable quality of life benefits.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: